LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it will be presenting at the upcoming Acumen/BioFin Rodman and Renshaw 4th Annual Global Healthcare Conference. Safi Bahcall, Ph.D., President and CEO, will discuss the Company’s oncology and inflammation drug discovery and development programs. The Synta presentation will begin at 2:55 PM (GMT) on Tuesday, May 15, 2007 and the Conference will be held at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
